Okapi Medical Announces New CEO and Successful Clinical Study
AKRON, Ohio, Jan. 14, 2020 /PRNewswire/ --Medical device company Okapi Medical is pleased to announce the appointment of CEO, Darren Obrigkeit, Ph.D.
- AKRON, Ohio, Jan. 14, 2020 /PRNewswire/ --Medical device company Okapi Medical is pleased to announce the appointment of CEO, Darren Obrigkeit, Ph.D.
- This appointment comes on the heels of a successful pre-clinical study involving the company's innovative wound closure technology.
- He will round out the veteran Okapi team, joining co-founders Dr. David Kay and William Fuller as well as a large group of seasoned medical advisors.
- Okapi's successful studies, conducted from August through December 2019, demonstrate the value of their patented wound closure technology, Cutiva.